# OnCo record guo-jun (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/guo-jun/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "guo-jun" ;
  schema:name "Jun Guo"@en ;
  schema:alternateName "郭军"@en ;
  schema:description "Jun Guo built China's melanoma programme around the acral and mucosal subtypes common in Asia, and led the trials that made toripalimab the first domestic PD-1 antibody approved."@en ;
  schema:url <https://onco.cc/people/guo-jun/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.bjcancer.org/>, <https://pubmed.ncbi.nlm.nih.gov/?term=Guo%20J%5BAuthor%5D%20melanoma%20Peking%20University%20Cancer%20Hospital%20toripalimab> ;
  onco:tag "china" ;
  schema:jobTitle "Professor; Department of Renal Cancer and Melanoma, Peking University Cancer Hospital" ;
  onco:related <https://onco.cc/institutions/csco/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/rcc/> ;
  onco:drugs <https://onco.cc/drugs/toripalimab/> ;
  onco:institutions <https://onco.cc/institutions/pku-cancer-hospital/> ;
  schema:affiliation <https://onco.cc/institutions/pku-cancer-hospital/> .